Literature DB >> 16952850

Dermatofibrosarcoma protuberans: review of 20-years experience.

Jaime Ruiz-Tovar1, Montserrat Fernández Guarino, María Eugenia Reguero Callejas, Asunción Aguilera Velardo, Juan Arano Bermejo, Luis Cabañas Navarro.   

Abstract

INTRODUCTION: Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue neoplasm with low-intermediate grade of malignancy. It is a locally aggressive tumour with a high recurrence rate. Surgical excision with adequate margins is the main treatment.
MATERIALS AND METHODS: We describe the clinicopathological features of 21 cases of DFSP. The mean size of the lesions was 5.6 cm, mostly located in trunk. 61.9% of the cases underwent surgical excision without previous biopsy. 52.4% of the patients presented positive margins, that required surgical extension.
RESULTS: The recurrence rate was 28.6% (6 cases), five of them local recurrences treated with new surgical excision with wide margins. Median period free of illness was 32.5 months. Medium follow-up period was 33.25 months.
CONCLUSIONS: DFSP has a locally high recurrence rate, that has been associated to inadequate surgical margins. The histological knowledge preoperatively would permit surgical excision with adequate margins, and probably this could reduce the recurrence rate. Radiotherapy could avoid the surgical extension of margins in these cases with positive ones. Chemotherapy could be indicated in metastasic cases. Most recurrences appear in the first 3 years, but it is important a long-term follow-up of these patients.

Entities:  

Mesh:

Year:  2006        PMID: 16952850     DOI: 10.1007/s12094-006-0067-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  9 in total

1.  Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Authors:  W B Bowne; C R Antonescu; D H Leung; S C Katz; W G Hawkins; J M Woodruff; M F Brennan; J J Lewis
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

Review 2.  Dermatofibrosarcoma protuberans.

Authors:  H M Gloster
Journal:  J Am Acad Dermatol       Date:  1996-09       Impact factor: 11.527

Review 3.  Dermatofibrosarcoma protuberans.

Authors:  William M Mendenhall; Robert A Zlotecki; Mark T Scarborough
Journal:  Cancer       Date:  2004-12-01       Impact factor: 6.860

4.  Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities.

Authors:  N J Lindner; M T Scarborough; G J Powell; S Spanier; W F Enneking
Journal:  Eur J Surg Oncol       Date:  1999-08       Impact factor: 4.424

Review 5.  The role of radiation therapy in the management of dermatofibrosarcoma protuberans.

Authors:  M T Ballo; G K Zagars; P Pisters; A Pollack
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-03-01       Impact factor: 7.038

Review 6.  Dermatofibrosarcoma protuberans: treatment and prognosis.

Authors:  E J Rutgers; B B Kroon; C E Albus-Lutter; E Gortzak
Journal:  Eur J Surg Oncol       Date:  1992-06       Impact factor: 4.424

7.  Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate.

Authors:  Stefanos V Labropoulos; Jonathan A Fletcher; Andre M Oliveira; Savvas Papadopoulos; Evangelia D Razis
Journal:  Anticancer Drugs       Date:  2005-04       Impact factor: 2.248

8.  Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

Authors:  Brian P Rubin; Scott M Schuetze; Janet F Eary; Thomas H Norwood; Sohail Mirza; Ernest U Conrad; James D Bruckner
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

9.  CD34 and factor XIIIa in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans.

Authors:  P Abenoza; T Lillemoe
Journal:  Am J Dermatopathol       Date:  1993-10       Impact factor: 1.533

  9 in total
  9 in total

1.  Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: a case report.

Authors:  Olivier Cottier; Maryse Fiche; Jean-Yves Meuwly; Jean-François Delaloye
Journal:  J Med Case Rep       Date:  2011-10-05

2.  A Rare Breast Tumor: Dermatofibrosarcoma Protuberans.

Authors:  Tevhide Bilgen Özcan; Ezgi Hacıhasanoğlu; Mehmet Ali Nazlı; Şefika Aksoy; Cem Leblebici; Canan Kelten Talu
Journal:  J Breast Health       Date:  2016-01-01

3.  Dermatofibrosarcoma protuberans: a case report and review of the literature.

Authors:  Sanjay Bhambri; Avani Desai; James Q Del Rosso; Narciss Mobini
Journal:  J Clin Aesthet Dermatol       Date:  2008-05

4.  Atrophic dermatofibrosarcoma protuberans.

Authors:  Ola Bakry; Abdalla Attia
Journal:  J Dermatol Case Rep       Date:  2012-03-27

5.  Dermatofibrosarcoma Protuberans of the Breast-a Rare Entity.

Authors:  Suvendu Maji; M J Paul; Supriya Sen
Journal:  Indian J Surg Oncol       Date:  2017-08-10

6.  Recurrent Dermatofibrosarcoma Protuberance: A Case Report.

Authors:  Shiv Raj Shah; Sujan Regmee; Dhiresh Kumar Maharjan; Prabin Bikram Thapa
Journal:  JNMA J Nepal Med Assoc       Date:  2021-11-15       Impact factor: 0.556

7.  Dermatofibrosarcoma protuberans: a case report.

Authors:  I Lym Chan; Sueli Carneiro; Mariana Menezes; Stella Ramos-E-Silva; Taíssa Magalhães; Tullia Cuzzi; Marcia Ramos-E-Silva
Journal:  Case Rep Dermatol       Date:  2014-05-09

Review 8.  Dermatofibrosarcoma Protuberans: Insights into a Rare Soft Tissue Tumor.

Authors:  Aliya Sarhan Al Barwani; Sawsan Taif; Reem Ahmed Al Mazrouai; Khamis Salim Al Muzahmi; Asif Alrawi
Journal:  J Clin Imaging Sci       Date:  2016-04-29

9.  Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine.

Authors:  Mai Takamura-Ishii; Takahiro Miura; Takaaki Nakaya; Katsuro Hagiwara
Journal:  Med Oncol       Date:  2017-09-01       Impact factor: 3.064

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.